Skip to main content
Premium Trial:

Request an Annual Quote

Ezose Teams with Merck on Diabetes Research

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement with Merck to conduct a diabetes biomarker discovery research project.

The collaboration will use Ezose's GlycanMap platform to identify changes in glycan patterns on post-translationally modified proteins from human subjects. Ezose did not disclose financial or other terms of the agreement but said that it builds on a series of collaborative studies previously conducted with the New Jersey-based drug giant.

Pine Brook, NJ-based Ezose's GlycanMap platform combines high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and bioinformatics to identify and quantitate glycans in complex biological samples.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.